Hubei Juneyao Health Drinks Co., Ltd

SSE:605388.SS

10.95 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 401.483281.358420.932357.623393.495276.587476.861433.532445.359141.263303.971293.084247.786213.199223.521223.365253.513141.863210.892305.796193.349267.756302.977337.588337.588
Cost of Revenue 269.221190.316295.981260.292279.128222.917360.011315.332344.93371.317196.108202.48164.737141.362125.883132.964142.282113.89105.639144.11191.455145.366133.06300
Gross Profit 132.26191.042124.95197.331114.36753.67116.849118.2100.42669.945107.86390.60483.0571.83797.63990.401111.23127.972105.253161.685101.894122.391169.914337.588337.588
Gross Profit Ratio 0.3290.3240.2970.2720.2910.1940.2450.2730.2250.4950.3550.3090.3350.3370.4370.4050.4390.1970.4990.5290.5270.4570.56111
Reseach & Development Expenses 10.07710.8938.0427.6397.3297.866.9595.7473.8764.2644.2414.3515.1136.7332.5462.2841.0810.8380.4040.4250.3390.9250.45200
General & Administrative Expenses 34.41311.91349.60918.91933.357-60.16278.056-15.38725.487-39.29653.391-13.49919.876-32.69442.283-6.58412.668-18.01911.929.13810.64-23.9049.12100
Selling & Marketing Expenses 75.041-23.559121.59851.73642.89643.2946.56953.12644.78652.66151.26441.98441.08654.457.92328.76827.6955.10238.52247.1435.079114.84348.16900
SG&A 109.454-11.646171.20784.1677.22580.6124.62537.73970.27313.365104.65528.48460.96221.706100.20622.18340.363-12.91750.44256.27845.71990.93957.2900
Other Expenses -0.562186.288-70.253-2.4990.174-1.0470.464-0.224-3.60456.371-31.02826.8011.3263.181-2.1832.1562.5824.393-0.036-8.2630.0720.6081.73500
Operating Expenses 118.969185.535108.99691.884.55488.46173.10383.270.5467477.86859.63767.40178.79181.66924.86542.62721.3747.51130.73237.342134.72637.806207.395207.395
Operating Income 13.293-94.49415.9555.53229.812-34.79145.84235.20933.559-6.34938.18637.17624.0553.09927.82978.79383.51617.3864.169136.74970.744-5.085136.932130.258130.258
Operating Income Ratio 0.033-0.3360.0380.0150.076-0.1260.0960.0810.075-0.0450.1260.1270.0970.0150.1250.3530.3290.1230.3040.4470.366-0.0190.4520.3860.386
Total Other Income Expenses Net -0.211-0.1040.366-2.4990.1743.7570.684-0.4442.721-1.171-0.563-0.6399.660.5129.3782.15617.56415.3516.494-2.4266.2655.4816.559-0.065-0.065
Income Before Tax 13.082-94.59816.32112.18234.519-31.03446.52634.76533.478-7.52137.62336.53724.1323.61125.64780.9586.09821.77364.133128.48670.817-4.478138.667130.193130.193
Income Before Tax Ratio 0.033-0.3360.0390.0340.088-0.1120.0980.080.075-0.0530.1240.1250.0970.0170.1150.3620.340.1530.3040.420.366-0.0170.4580.3860.386
Income Tax Expense 3.46-14.1214.5482.6078.828-8.1839.9728.8528.389-2.3963.719.8956.2540.8976.55221.64221.6725.37515.8132.21218.23-1.47733.57233.83933.839
Net Income 10.907-78.53714.6588.61226.15-24.93934.83823.76123.917-5.12533.48927.14818.2742.97419.52260.05664.43616.45448.37796.31152.693-3.027105.21696.57296.572
Net Income Ratio 0.027-0.2790.0350.0240.066-0.090.0730.0550.054-0.0360.110.0930.0740.0140.0870.2690.2540.1160.2290.3150.273-0.0110.3470.2860.286
EPS 0.02-0.1390.0250.0150.061-0.0580.0810.0550.056-0.0120.0730.0590.040.0060.0450.140.150.0440.130.270.15-0.0080.290.2680.269
EPS Diluted 0.02-0.1390.0250.0150.061-0.0580.0810.0550.056-0.0120.0730.0590.040.0060.0450.140.150.0440.130.270.15-0.0080.290.2680.269
EBITDA 13.268-95.05617.00329.4434.801-21.19960.29245.97944.703-0.98243.70146.45734.06212.58434.64986.50290.9846.60264.133136.74970.817-4.478138.667134.82134.82
EBITDA Ratio 0.033-0.3380.040.0820.088-0.0770.1260.1060.1-0.0070.1440.1590.1370.0590.1550.3870.3590.0470.3040.4470.366-0.0170.4580.3990.399